128 related articles for article (PubMed ID: 6433363)
1. Effects of the serine protease inhibitor gabexate mesilate on purified pancreatic phospholipase A2.
Hesse B; Lankisch PG; Kunze H
Pharmacol Res Commun; 1984 Jul; 16(7):637-45. PubMed ID: 6433363
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of porcine pancreas phospholipase A2 activation by gabexate mesilate.
Schädlich HR; Büchler M; Beger HG
Klin Wochenschr; 1989 Feb; 67(3):160-2. PubMed ID: 2494376
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinine.
Freise J; Magerstedt P; Schmid K
Enzyme; 1983; 30(3):209-12. PubMed ID: 6194983
[TBL] [Abstract][Full Text] [Related]
4. In vitro inhibition of phospholipase A2 by gabexate mesilate, camostate, and aprotinine.
Freise J; Wittenberg H; Magerstedt P
Klin Wochenschr; 1989 Feb; 67(3):149-52. PubMed ID: 2467043
[TBL] [Abstract][Full Text] [Related]
5. Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis.
Freise J; Schmidt FW; Magerstedt P; Schmid K
Clin Biochem; 1985 Aug; 18(4):224-9. PubMed ID: 2412725
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of gabexate mesilate on pancreatic phospholipase A2-mediated hydrolysis of ghost membranes.
Nishijima J; Okamoto M; Nakaguchi K; Ogawa M; Yamano T; Mori T
Gen Pharmacol; 1985; 16(3):177-82. PubMed ID: 3926598
[TBL] [Abstract][Full Text] [Related]
7. Effects of the serine protease inhibitors FOY and FOY 305 on phospholipase A1 (EC 3.1.1.32) activity in rat - liver lysosomes.
Kunze H; Bohn E
Pharmacol Res Commun; 1983 May; 15(5):451-9. PubMed ID: 6412250
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of acute pancreatitis with a synthetic protease and phospholipase A2 inhibitor gabexate mesilate].
Freise J
Fortschr Med; 1983 Aug; 101(31-32):1432-6. PubMed ID: 6194089
[TBL] [Abstract][Full Text] [Related]
9. Influence of aprotinin and gabexate mesilate on arachidonic acid release by the Ca-ionophore A 23187 in the lung.
Seeger W; Wolf H; Graubert E; Moser U; Neuhof H; Roka L
Adv Exp Med Biol; 1983; 156():553-67. PubMed ID: 6190378
[TBL] [Abstract][Full Text] [Related]
10. Effects of the anti-inflammatory serine esterase inhibitor, FOY, on phospholipase A2 (EC 3.1.1.4) activity in rabbit polymorphonuclear leukocytes.
Kunze H; Bohn E; Damerau B
Pharmacol Res Commun; 1983 Oct; 15(9):869-78. PubMed ID: 6417683
[TBL] [Abstract][Full Text] [Related]
11. [Phospholipase A2 inhibitors in hemorrhagic-necrotizing pancreatitis. Animal experiment evaluation of a new treatment concept].
Kahle M; Klein U; König W; Martin U; Alles JU
Z Gastroenterol; 1985 Dec; 23(12):687-93. PubMed ID: 3937346
[TBL] [Abstract][Full Text] [Related]
12. Lysolecithin concentration in pancreatic tissue during therapy with phospholipase A2-inhibitors in acute necrotizing pancreatitis.
Kahle M; König H; Filler RD
Klin Wochenschr; 1989 Feb; 67(3):177-9. PubMed ID: 2494378
[TBL] [Abstract][Full Text] [Related]
13. [Effect of FOY-305 on the activity and secretion of pancreatic enzymes in vitro].
Stöckmann F; Göke B; Otto J; Lankisch PG; Creutzfeldt W
Z Gastroenterol; 1984 Jun; 22(6):311-7. PubMed ID: 6205521
[TBL] [Abstract][Full Text] [Related]
14. Are phospholipid-binding proteins in vivo phospholipase inhibitors?
Poensgen J
Klin Wochenschr; 1989 Feb; 67(3):163-5. PubMed ID: 2494377
[TBL] [Abstract][Full Text] [Related]
15. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients].
Freise J; Melzer P; Schmidt FW; Horbach L
Z Gastroenterol; 1986 Apr; 24(4):200-11. PubMed ID: 3087076
[TBL] [Abstract][Full Text] [Related]
16. Effects of gabexate mesilate (FOY) on amylase and phospholipase A2 in human serum and pancreatic juice.
Caronna R; Diana L; Nofroni I; Sibio S; Catinelli S; Sammartino P; Chirletti P
Dig Dis Sci; 2005 May; 50(5):868-73. PubMed ID: 15906759
[TBL] [Abstract][Full Text] [Related]
17. Gabexate mesilate improves pancreatic microcirculation and reduces lung edema in a rat model of acute pancreatitis.
Chen HM; Shyr MH; Chen MF
J Formos Med Assoc; 1997 Sep; 96(9):704-9. PubMed ID: 9308324
[TBL] [Abstract][Full Text] [Related]
18. The effect of gabexate mesilate on the outcome of acute hemorrhagic pancreatitis in pigs.
Ristkari SK; Rämö OJ; Kiviniemi H; Gröhn P; Mahlberg K; Mokka RE
Res Exp Med (Berl); 1989; 189(1):1-8. PubMed ID: 2496446
[TBL] [Abstract][Full Text] [Related]
19. FOY: [ethyl P-(6-guanidinohexanoyloxy) benzoate] methanesulfonate as a serine proteinase inhibitor. I. Inhibition of thrombin and factor Xa in vitro.
Ohno H; Kosaki G; Kambayashi J; Imaoka S; Hirata F
Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):579-88. PubMed ID: 6449757
[No Abstract] [Full Text] [Related]
20. Gabexate mesilate (FOY) inhibition of amylase and phospholipase A(2) activity in sow pancreatic juice.
Caronna R; Loretta D; Campedelli P; Catinelli S; Nofroni I; Sibio S; Sinibaldi G; Chirletti P
J Invest Surg; 2003; 16(6):345-51. PubMed ID: 14708545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]